发明名称 |
IMMUNOTHERAPY OF CANCER THROUGH COMBINATION OF LOCAL AND SYSTEMIC IMMUNE STIMULATION |
摘要 |
Provided herein are compositions and methods for immunotherapy of cancers, said methods combining systemic vaccination with a recombinant expression vector encoding a viral antigen and/or a cancer specific tumor antigen(s) to induce activated CD8 T-cells, with a local (e.g., intratumoral) immune stimulation using standard or modified application of a TLR agonist, to induce local inflammatory and innate immune responses which recruit T-cells to the tumor. |
申请公布号 |
US2016058852(A1) |
申请公布日期 |
2016.03.03 |
申请号 |
US201514621685 |
申请日期 |
2015.02.13 |
申请人 |
Immune Design Corp. |
发明人 |
Ter Meulen Jan Henrik;Paya Cuenca Carlos V. |
分类号 |
A61K39/00;A61K45/06;A61K39/12;A61K39/07;A61K39/39;C12N7/00 |
主分类号 |
A61K39/00 |
代理机构 |
|
代理人 |
|
主权项 |
1. A method of treating a cancer comprising:
a) administering to a subject a first composition comprising a vector particle, the vector particle comprising a recombinant expression vector wherein the recombinant expression vector comprises a polynucleotide encoding a cancer-associated antigen, and wherein the polynucleotide is operatively linked to at least one regulatory expression sequence, thereby inducing an immune response against the cancer-associated antigen in the subject; and b) administering intratumorally, peritumorally, intranodally or intravesically to the subject a second composition comprising a TLR4 agonist wherein the composition does not comprise antigen; wherein the first composition and the second composition each further comprise a pharmaceutically suitable excipient, and wherein the first composition and second composition are administered concurrently or sequentially. |
地址 |
Seattle WA US |